Prosecution Insights
Last updated: November 20, 2026
Application No. 18/961,277

PROSTHETIC VALVES WITH INFORMATION INDICATORS

Non-Final OA §102§103
Filed
Nov 26, 2024
Priority
Jun 23, 2022 — provisional 63/354,812 +1 more
Examiner
STEWART, ALVIN J
Art Unit
3774
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Edwards Lifesciences Corporation
OA Round
1 (Non-Final)
82%
Grant Probability
Favorable
1-2
OA Rounds
10m
Est. Remaining
83%
With Interview

Examiner Intelligence

Grants 82% — above average
82%
Career Allowance Rate
919 granted / 1118 resolved
+12.2% vs TC avg
Minimal +1% lift
Without
With
+0.8%
Interview Lift
resolved cases with interview
Typical timeline
2y 10m
Avg Prosecution
31 currently pending
Career history
1160
Total Applications
across all art units

Statute-Specific Performance

§101
1.9%
-38.1% vs TC avg
§103
37.1%
-2.9% vs TC avg
§102
35.1%
-4.9% vs TC avg
§112
14.7%
-25.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1118 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-6, 8, 14 and 15 are rejected under 35 U.S.C. 102(a)(2) as being anticipated by Iyer et al US Patent Pub. 2023/0248513A1. Iyer et al discloses a prosthetic valve (1800) comprising an annular frame (1804) movable between a compressed diameter in a radially compressed state and a deployed diameter in a radially expanded state, the frame comprising: a plurality of intersecting angled struts (1874a-b) and a plurality of vertical struts (1852 and 1880-81), wherein each vertical strut extends between a vertical strut inflow end (See figure below) and an opposite vertical strut outflow end (see figure below), and wherein the plurality of vertical struts comprises: a plurality of commissure struts (1846), each commissure strut comprising a commissure window (See holes below); and a plurality of non-commissural vertical struts; at least one externally formed information indicator (1860, see also paragraphs 15 and 110 disclosing that a marker can be located in the node 2116a) formed along at least one of the vertical struts (1880-81); and a valvular structure mounted within the frame and comprising a plurality of leaflets configured to regulate flow through the prosthetic valve (see Figs. 14a-c). Regarding claims 2 and 4, as disclosed in paragraph 110 the node 2116a can have a radiopaque marker in addition to the other marker having a letter “d” (See figure below). PNG media_image1.png 708 643 media_image1.png Greyscale Regarding claim 3, see element 1860 as the indicator in one of the commissure struts. Regarding claim 5, in paragraph 110 discloses that a radiopaque marker can be attached to the node 2116a, therefore, if the marker is a coating or is physically attached to that node, then at least the radiopaque node will be slightly bigger than the original strut. Regarding claim 6, paragraph 110 discloses that additional radiopaque markers can be attached to the struts, therefore, the multiple radiopaque markers in the implant read on the claimed subject matter. Regarding claim 8, the frame further comprises at least two support struts (1874) extending between at least two adjacent vertical struts and intersecting with each other at a support apex (1842), and wherein at least one support strut extends from the at least one externally formed information indicator (See figure below for the Examiners interpretation). PNG media_image2.png 312 626 media_image2.png Greyscale Regarding claim 14, see figure below disclosing the two angle struts intersecting the inflow end and another two angled struts intersecting the outflow end of the vertical strut. PNG media_image3.png 532 588 media_image3.png Greyscale Regarding claim 15, as disclosed in paragraph 110, radiopaque markers can be attached to a strut and a node to have fluoroscopic visualization from outside the body. Therefore, it is well known in the art to attached the markers to the struts using several techniques including crimping, coating, riveting, press-fitting and mechanical interlocking all these techniques will make the market (indicator) wider that the strut and the vertical strut it is formed along the marker (indicator). Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim 7 is rejected under 35 U.S.C. 103 as being unpatentable over Iyer et al US Patent Pub. 2023/0248513A1 in view of Guttenberg et al US Patent Pub. 2022/0039945A1. Iyer et al discloses an implant having an indicator in the shape of a letter and another additional indicator as a marker in the node of the strut as disclosed in paragraph 110 (see figure above). However, Iyer et al does not disclose an indicator in the shape of a digit. Guttenberg et al discloses a heart implant comprising easily identifying indicators to provide information about the heart valve measurements, type and valve model. The Guttenberg et al reference uses this information so it can be seen from outside of the body, post implantation (see paragraph 47). It would have been obvious to one ordinary skill in the art to combine the letters of the Lyer et al reference with the numbers of the Guttenberg et al reference in order to use this information for identifying the size of the implant from outside of the body, post implantation. Allowable Subject Matter Claims 9-13 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. US 2017/0000604 --- See Fig. 9A disclosing digit indicators. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ALVIN J STEWART whose telephone number is (571)272-4760. The examiner can normally be reached Monday-Friday 8:30AM-6PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Thomas Barrett can be reached at 571-272-4746. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ALVIN J STEWART/Primary Examiner, Art Unit 3799 10/16/26
Read full office action

Prosecution Timeline

Nov 26, 2024
Application Filed
Oct 20, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12773313
TRANSLUMINAL DELIVERY SYSTEM
3y 4m to grant Granted Oct 27, 2026
Patent 12758391
TALUS IMPLANT
4y 5m to grant Granted Oct 13, 2026
Patent 12758403
BIONIC JOINT AND A PROSTHESIS FOR REPLACING AN ELBOW JOINT
3y 0m to grant Granted Oct 13, 2026
Patent 12751844
UNCAGING STENT
2y 6m to grant Granted Oct 06, 2026
Patent 12746121
TRANS-SEPTAL DELIVERY SYSTEM AND METHODS OF USE
3y 6m to grant Granted Sep 29, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
82%
Grant Probability
83%
With Interview (+0.8%)
2y 10m (~10m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1118 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month